Live Dana-Farber Cancer Institute News with Latest Updates

Live Dana-Farber Cancer Institute news and developments with the latest updates. Check out current Dana-Farber Cancer Institute news stories and find out what happened, what is going on with Dana-Farber Cancer Institute. Recent news updates about Dana-Farber Cancer Institute
Dana-Farber Cancer Institute to Establish Riney Family Multiple Myeloma Initiative
Kathleen McDaniel named Senior Vice President, Chief People Officer
More than 110 Dana-Farber-affiliated physicians recognized as Top Doctors
Dana-Farber Cancer Institute to Establish Chen-Huang Center for EGFR Mutant Lung Cancers
Kevin Haigis to become Chief Research Officer at Dana-Farber Cancer Institute
Study reveals intersection of sexual orientation and demographic factors
Dana-Farber research supports new indication for a prostate cancer drug
Dana-Farber researcher awarded Victoria Mock New Investigator Award
Myles Brown, MD receives 2019 AACR Distinguished Lectureship in Breast Cancer Research award
New technique to determine protein structures may solve biomedical puzzles
New targeted drugs show promise in patients with advanced HER2-positive breast cancer in
Treatment with PD-1 inhibitor prior to stem cell transplant is safe
Dana-Farber scientists present promising findings in multiple myeloma at ASH Annual Meeting
Use of venetoclax in reduced-intensity transplant conditioning regimen
Genomic features of AML in patients over age 60 can predict success of bone marrow stem cell
Dana-Farber Cancer Institute Faculty named AAAS 2019 Fellows
Dana-Farber researchers to present more than 40 studies at 2019 ASH Annual Meeting
Dana-Farber joins with leading Boston teaching hospitals and universities
Dana-Farber Cancer Institute researcher awarded funding from Chan Zuckerberg Initiative for Open
Dana-Farber Researcher awarded 2019 Paul Marks Prize for Cancer Research
Dana-Farber named one of most noteworthy MA companies and non-profits led by women
Dana-Farber Cancer Institute earns “LGBTQ Health Care Equality Top Performer” Designation
Study finds racial disparities in culturally competent cancer care
Small molecule inhibitor shows clinical activity in lung and colorectal cancer patients
Dana-Farber Cancer Institute launches new national advertising campaign
Dana-Farber Cancer Institute faculty elected to National Academy of Medicine
Dana-Farber Cancer Institute Receives Largest Gift Ever, a Record-Breaking $63 Million
Eric Winer, MD honored with Jill Rose Award by Breast Cancer Research Foundation
Cause of drug resistance in a type of intestinal tumors identified
William G. Kaelin, MD, of Dana-Farber Cancer Institute wins 2019 Nobel Prize
New blood test capable of detecting multiple types of cancer
Dana-Farber Cancer Institute and Jimmy Fund debut new visual identity
Resistance to immune checkpoint blocker drug linked to metabolic imbalance
Chronic insomnia can be cured in cancer survivors with a basic, one-session sleep education class
Dana-Farber Cancer Institute receives $5 million gift to create Edward P. Evans Center
Study shows benefit of PARP inhibitor for some ovarian cancer patients
Beth Mittendorf, MD, PhD will lead new Stand Up to Cancer research team
Statement on Medical Deferred Action Program – August 31, 2019
Dana-Farber/Brigham and Women’s Cancer Center receives largest individual gift for glioblastoma
Exposure to second-hand e-cigarette aerosols increasing among young people, Dana-Farber study finds
Dana-Farber Cancer Institute is awarded its fourth consecutive designation as a Magnet organization
“Stapled” antimicrobial peptides could combat antibiotic resistance
Exercise associated with benefit to patients with advanced colorectal cancer
Inherited pancreatic cancer risk mutation identified
U.S. News & World Report Names Dana-Farber/Brigham and Women’s Cancer Center Among Best
AI tool identifies cancer outcomes using radiology reports
Dana-Farber physician-scientist David Braun honored as Next Gen Innovator
To understand a childhood brain tumor, researchers turn to single-cell analysis